Tavistock Group Life Sciences

Resources to let scientists focus on science.

Tavistock Life Sciences (TLS) invests in a select number of public and early-stage private life science opportunities with exceptional technology profiles and clear commercial opportunity. Currently our portfolio includes companies such as Ambrx, Kalypsys and Iapyx.

TLS partners with inventors and scientists on compelling opportunities.
We enable parties to maximize value and wealth within a stimulating
environment that fuels the creation of ideas – the basis of all good science.
TLS prides itself on being a dynamic organization, able to respond quickly
and reliably to the needs of our scientists while maintaining a long-term commitment to every promising project we fund.